$aztr
Breaking: $AZTR sees a surge in social engagement with [-----] interactions in [--] hours, driven by positive clinical trial data and the CEO's past successes. The community is buzzing with optimism.
About $aztr
$AZTR is a decentralized digital asset and its associated ecosystem.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Month: [-------] +139%
[--] Months: [---------] +131%
[--] Year: [---------] -2.20%
1-Year High: [-------] on 2025-08-27
1-Year Low: [--] on 2026-01-01
Engagements by network (24h): X: [-----] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-13
1-Year Low: [--] on 2025-12-21
Mentions by network (24h): X: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $aztr in the last [--] hours which is down 17% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-12-21
The most influential creators that mention $aztr in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @greatstockpicks | [--] | [------] | [--] | [-----] |
| @boogeymantradez | [--] | [-----] | [--] | [-----] |
| @WolfofWallSt461 | [--] | [-----] | [--] | [---] |
| @LucyTrader98 | [--] | [---] | [--] | [--] |
| @buysellshort | [--] | [-------] | [--] | [--] |
| @simpletrader36 | [--] | [-----] | [--] | [--] |
| @stockplaymaker1 | [--] | [-------] | [--] | [--] |
| @daaapollo908 | [--] | [---] | [--] | [--] |
| @RaZE___SoViEt | [--] | [---] | [--] | [--] |
| @MapagoTrades | [--] | [---] | [--] | [--] |
Sentiment: 86%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 86%
Daily Average: 84%
[--] Month: 69% +19%
[--] Months: 69% -31%
[--] Year: 69% -17%
1-Year High: 100% on 2025-02-16
1-Year Low: 9% on 2025-12-03
Most Supportive Themes:
- Positive Clinical Trial Data: (67%) Posts highlight excellent safety and strong efficacy signals from Phase 1b trials, particularly for Netherton syndrome.
- CEO's Past Success: (33%) The CEO's previous company exit for $6.3 billion is frequently mentioned as a positive indicator for $AZTR's potential.
Most Critical Themes:
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing